Safety &Efficacy of CF101 to Subjects With Uveitis
Condition(s):Uveitis, Posterior; Uveitis, IntermediateLast Updated:February 1, 2018Withdrawn
Hide Studies Not Open or Pending
Condition(s):Uveitis, Posterior; Uveitis, IntermediateLast Updated:February 1, 2018Withdrawn
Condition(s):Uveitis, Intermediate; Uveitis, PosteriorLast Updated:July 5, 2019Completed
Condition(s):Posterior UveitisLast Updated:November 26, 2019Completed
Condition(s):Non-infectious Intermediate and Posterior UveitisLast Updated:March 27, 2019Terminated
Condition(s):Intermediate Uveitis; Posterior UveitisLast Updated:April 14, 2011Completed
Condition(s):Uveitis, Posterior; Uveitis, Intermediate; PanuveitisLast Updated:August 3, 2021Terminated
Condition(s):Non-infectious Intermediate and Posterior UveitisLast Updated:July 2, 2017Completed
Condition(s):Uveitis, PosteriorLast Updated:October 30, 2023Recruiting
Condition(s):UveitisLast Updated:July 7, 2021Completed
Condition(s):Diabetic Macular Edema, Cystoid Macular Edema, Chorodial Neovascularzation, Posterior UveitisLast Updated:October 29, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.